Discover 626 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nebraska provides a variety of paid research opportunities for both healthy volunteers and individuals with specific medical concerns. Research institutions in Omaha, Lincoln, and Bellevue are recruiting participants, offering access to advanced treatments and dedicated medical care.
Filter
1
Filter results
Results: 626
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Shirley NY, New Haven CT, Mineola NY, The Bronx NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for
Metastatic Non Small Cell Lung Cancer
Location: New York NY, Montreal, Camden NJ, Richmond VA,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT04614103
Phase2, Recruiting
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Peoria IL, Boston MA, Middletown NJ, Philadelphia PA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06843590
Phase2, Recruiting
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
for
Leukemia, Lymphoma, Multiple Myeloma,
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT04898790
Recruiting
Contoura With Phorcides Compared to Wavefront Optimized LASIK
Location: New York NY, Staten Island NY, Richmond VA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06229210
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Scarborough ME, Providence RI, New Haven CT, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Red Bank NJ, Havertown PA, Johnson City NY,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
for
Recurrent Melanoma (Skin), Metastatic Melanoma,
Location: Philadelphia PA, Miami FL, Pittsburgh PA,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05655312
Phase1, Phase2, Recruiting
SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
for
Cystic Fibrosis
Location: Portland ME, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Aridis Pharmaceuticals, Inc.
Sex: All
Age: 18 - 49
Code: NCT03669614
Phase1, Phase2, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Norwich CT, White Plains NY, New York NY, Belleville NJ,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
To Study the Effects of Refractive Surgery on OCT Measurements in the Eye
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
for
Communication
Location: The Bronx NY, Pittsburgh PA, Columbus OH, Birmingham AL,
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT05591066
Recruiting
Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair
for
Heart Failure
Location: Newark NJ, Montreal, Philadelphia PA, Lancaster PA,
Sponsor: Acorn Cardiovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT00630266
Phase2, Recruiting
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
for
Peripheral Arterial Disease
Location: Manhasset NY, Atlanta GA, Minneapolis MN, Omaha NE,
Sponsor: North Texas Veterans Healthcare System
Sex: All
Age: 40 - 70+
Code: NCT02660866
Recruiting
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Boston MA, New York NY, Durham NC, Cleveland OH,